{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:59:05Z","timestamp":1785513545889,"version":"3.56.0"},"reference-count":13,"publisher":"Mattioli1885","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Introduction: Low-dose oral minoxidil (LDOM) has become an increasingly used therapy for alopecia. While dose-dependent hypertrichosis is the most common side effect, gastrointestinal (GI) adverse effects are plausible due to smooth muscle relaxation, but they have not been systematically reported in clinical studies. Objectives: To investigate the frequency and characteristics of GI adverse effects in patients treated with LDOM for alopecia. Methods: We conducted a prospective observational study at a trichology unit including patients attending their second consultation after initiating oral minoxidil between May and August 2025. A structured questionnaire assessed new GI symptoms, temporal relationship with treatment, and concomitant medication use. Results: Among 302 patients (218 females, 84 males; mean age 46 years), 22 (7.3%) reported new GI symptoms. The most frequent symptoms were flatulence (N=18), heartburn (N=13), abdominal distension (N=12), abdominal pain (N=10), and aerophagia (N=7). Symptoms resolved after discontinuation in 15 of 16 cases and recurred after reintroduction in 14 of 15. A dose-response association was observed (mean dose in patients with GI symptoms 2.7 \u00b1 1.6 mg vs. 1.3 \u00b1 1.2 mg in those without, P=0.01). GI side effects were more common in males (15.5%) than in females (4.1%, P&lt;0.001) and in patients treated with concomitant vasodilators (25.6% vs. 4.6%, P&lt;0.001). Conclusions: GI complaints, particularly aerophagia, abdominal pain or distension, and flatulence, appear to be underrecognized adverse effects of LDOM. Although generally mild, these symptoms may affect adherence and quality of life. Clinicians should inquire about GI complaints, especially in male patients receiving higher doses or concomitant vasodilators.<\/jats:p>","DOI":"10.5826\/dpc.1603a7007","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:08:20Z","timestamp":1785510500000},"page":"7007","source":"Crossref","is-referenced-by-count":0,"title":["Gastrointestinal Side Effects of Low-Dose Oral Minoxidil in Patients with Alopecia: An Underrecognized Association"],"prefix":"10.5826","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2642-1773","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Soares","sequence":"first","affiliation":[{"name":"University Hospital, ULS Coimbra. Faculty of Medicine, University of Coimbra. Portugal."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0289-6229","authenticated-orcid":false,"given":"Manuel","family":"Mart\u00ednez-Sell\u00e9s","sequence":"first","affiliation":[{"name":"Cardiology Department, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n, CIBERCV. Universidad Europea. Universidad Complutense. Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6573-5292","authenticated-orcid":false,"given":"Rui","family":"Oliveira Soares","sequence":"first","affiliation":[{"name":"3. Centro de Dermatologia de Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27750","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"10.5826\/dpc.1603a7007_ref1","doi-asserted-by":"crossref","unstructured":"Perera E, Sinclair R. Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study. F1000Research. 2017;6:1650. DOI:10.12688\/f1000research.11775.1","DOI":"10.12688\/f1000research.11775.1"},{"key":"10.5826\/dpc.1603a7007_ref2","doi-asserted-by":"crossref","unstructured":"Va\u00f1\u00f3-Galv\u00e1n S, Pirmez R, Hermosa-Gelbard A, et al. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651. DOI:10.1016\/j.jaad.2021.02.054","DOI":"10.1016\/j.jaad.2021.02.054"},{"key":"10.5826\/dpc.1603a7007_ref3","doi-asserted-by":"crossref","unstructured":"Jimenez-Cauhe J, Lo Sicco KI, Shapiro J, et al. Characterization and Management of Adverse Events of Low-Dose Oral Minoxidil Treatment for Alopecia: A Narrative Review. J Clin Med. 2025;14(6):1805. DOI:10.3390\/jcm14061805","DOI":"10.3390\/jcm14061805"},{"key":"10.5826\/dpc.1603a7007_ref4","doi-asserted-by":"crossref","unstructured":"Jimenez\u2010Cauhe J, Saceda\u2010Corralo D, Rodrigues\u2010Barata R, et al. Safety of low\u2010dose oral minoxidil treatment for hair loss. A systematic review and pooled\u2010analysis of individual patient data. Dermatol Ther. 2020;33(6) :e14106. DOI:10.1111\/dth.14106","DOI":"10.1111\/dth.14106"},{"key":"10.5826\/dpc.1603a7007_ref5","doi-asserted-by":"crossref","unstructured":"Randolph M, Tosti A. Oral minoxidil treatment for hair loss: A review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737-746. DOI:10.1016\/j.jaad.2020.06.1009","DOI":"10.1016\/j.jaad.2020.06.1009"},{"key":"10.5826\/dpc.1603a7007_ref6","doi-asserted-by":"crossref","unstructured":"Liu C, Liu X, Shi T, et al. Efficacy and safety of oral minoxidil in the treatment of alopecia: a single-arm rate meta-analysis and systematic review. Front Pharmacol. 2025;16:1556705. DOI:10.3389\/fphar.2025.1556705","DOI":"10.3389\/fphar.2025.1556705"},{"key":"10.5826\/dpc.1603a7007_ref7","doi-asserted-by":"crossref","unstructured":"De Ponti F, Giaroni C, Cosentino M, Lecchini S, Frigo G. Calcium-channel blockers and gastrointestinal motility: Basic and clinical aspects. Pharmacol Ther. 1993;60(1):121-148. DOI:10.1016\/0163-7258(93)90024-8","DOI":"10.1016\/0163-7258(93)90024-8"},{"key":"10.5826\/dpc.1603a7007_ref8","doi-asserted-by":"crossref","unstructured":"Sun WM, Doran S, Jones KL, et al. Effects of nitroglycerin on liquid gastric emptying and antropyloroduodenal motility. Am J Physiol Gastrointest Liver Physiol. 1998;275(5):G1173-G1178. DOI:10.1152\/ajpgi.1998.275.5.G1173","DOI":"10.1152\/ajpgi.1998.275.5.G1173"},{"key":"10.5826\/dpc.1603a7007_ref9","doi-asserted-by":"crossref","unstructured":"Clemente CM, Ara\u00fajo PV, Palheta RC, et al. Sildenafil inhibits duodenal contractility via activation of the NO\u2013K+ channel pathway. Fundam Clin Pharmacol. 2008;22(1):61-67. DOI:10.1111\/j.1472-8206.2007.00549.x","DOI":"10.1111\/j.1472-8206.2007.00549.x"},{"key":"10.5826\/dpc.1603a7007_ref10","doi-asserted-by":"crossref","unstructured":"Hasler WL. Nausea, Gastroparesis, and Aerophagia. J Clin Gastroenterol. 2005;39(5):S223-S229. DOI:10.1097\/01.mcg.0000156111.69232.f2","DOI":"10.1097\/01.mcg.0000156111.69232.f2"},{"key":"10.5826\/dpc.1603a7007_ref11","doi-asserted-by":"crossref","unstructured":"McCreight LJ, Bailey CJ, Pearson ER. Metformin and the gastrointestinal tract. Diabetologia. 2016;59(3):426-435. DOI:10.1007\/s00125-015-3844-9","DOI":"10.1007\/s00125-015-3844-9"},{"key":"10.5826\/dpc.1603a7007_ref12","doi-asserted-by":"crossref","unstructured":"Bruno G, Zaccari P, Rocco G, et al. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. World J Gastroenterol. 2019;25(22):2706-2719. DOI:10.3748\/wjg.v25.i22.2706","DOI":"10.3748\/wjg.v25.i22.2706"},{"key":"10.5826\/dpc.1603a7007_ref13","doi-asserted-by":"crossref","unstructured":"Frydrych A, Jurowski K. Toxicity of minoxidil \u2013 Comprehensive in silico prediction of main toxicity endpoints: Acute toxicity, irritation of skin and eye, genetic toxicity, health effect, cardiotoxicity and endocrine system disruption. Chem Biol Interact. 2024;393:110951. DOI:10.1016\/j.cbi.2024.110951","DOI":"10.1016\/j.cbi.2024.110951"}],"container-title":["Dermatology Practical &amp; Conceptual"],"original-title":[],"link":[{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/download\/7007\/3945","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/download\/7007\/3946","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/download\/7007\/3945","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:08:22Z","timestamp":1785510502000},"score":1,"resource":{"primary":{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/view\/7007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5826\/dpc.1603a7007","relation":{"has-manifestation":[{"id-type":"other","id":"1-84-7007-g3945","asserted-by":"subject"},{"id-type":"other","id":"1-84-7007-g3946","asserted-by":"subject"}],"is-part-of":[{"id-type":"doi","id":"10.5826\/dpc.1603a%a","asserted-by":"subject"}]},"ISSN":["2160-9381"],"issn-type":[{"value":"2160-9381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"article-number":"18"}}